Mirtazapine for anorexia nervosa with depression.
OBJECTIVE
To report the use of Mirtazapine in the treatment of anorexia nervosa with depression primarily regarding its propensity for weight gain.


METHODS
We present an outpatient case report of anorexia nervosa with depression. The patient's subsequent progress was recorded.


RESULTS
The patient gained 2.5 kg within 3 months to eventually attain a body mass index of 15 after 5 months. Her depression achieved full remission at 6 weeks of treatment.


CONCLUSIONS
Mirtazapine is the choice medication in this case. However, treating depression requires caution, given these patients' physical vulnerability. Controlled trials of Mirtazapine for anorexia nervosa are needed.
Jaafar
Nik Ruzyanei Nik
NR
Department of Psychiatry, Faculty of Medicine, Hospital Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Kuala Lumpur, Cheras, Malaysia. nikruzyanei@yahoo.com
Daud
Tuti Iryani Mohd
TI
Rahman
Fairuz Nazri Abdul
FN
Baharudin
Azlin
A
D000293:Adolescent; D000856:Anorexia Nervosa / Q000188:drug therapy*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005196:Family Therapy; D005260:Female; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D010348:Patient Care Team; D013405:Suicide / Q000523:psychology; D000092864:Suicide Prevention
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine